Which anesthesia is safer for Kids' brains? new trial to find out
NCT ID NCT07194109
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study will compare two anesthesia drugs—remimazolam and propofol—in 558 children aged 3 to 6 who are having their tonsils or adenoids removed. The main goal is to see which drug leads to better brain development 1 to 3 years after surgery. Children will be randomly assigned to receive one of the two drugs during their operation, and their thinking and memory skills will be tested later.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- remimazolam
- What this could lead to
- If remimazolam proves better for children's brain development after surgery, it could become a preferred anesthesia option for young kids.
- What could go wrong
- This is a Phase 4 study comparing two known drugs, so no major breakthrough is expected. Results may show no difference or be limited to this specific surgery and age group.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADENOTONSILLAR HYPERTROPHY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Heartbeat clues may flag surgery risks in children
- Brain wave monitor may cut opioid use in Kids' tonsil surgery
- Nose spray sedation for kids before surgery shows promise
- Asthma drug tested as painkiller for kids after tonsillectomy
- Zap instead of snip: electric pulses may treat Kids' blocked airways
- Which anesthesia drug calms kids best after tonsil surgery?